Crossmark

The Impact of Radiotherapy Delay in Breast Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures

Crossref DOI link: https://doi.org/10.1245/s10434-021-10512-1

Published Online: 2021-07-29

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bleicher, Richard J.

Moran, Meena S.

Ruth, Karen

Edge, Stephen B.

Dietz, Jill M.

Wilke, Lee G.

Stearns, Vered

Kurtzman, Scott H.

Klein, Jonah

Yao, Katharine A.
Funding

Funding for this research was provided by:

Marlyn Fein Chapter of the Fox Chase Cancer Center Board of Associates (Private Funding)

United States Public Health Services grant (P30CA006927)
License Information

Text and Data Mining valid from 2021-07-29

Version of Record valid from 2021-07-29
More Information

Article History

Received: 19 April 2021

Accepted: 29 June 2021

First Online: 29 July 2021

Disclosures

: Lee Wilke—Founder and minority stock owner Elucent Medical; biopsy clip for breast localization; not related to the described work, but reported.

Document is current

Any future updates will be listed below